β-glucan, which upregulates the expression of Cdc42, Rac1, and RhoA, enhances cell migration and proliferation, and ultimately promotes intestinal mucosal wound recovery, also represents a therapeutic potential for IBD via mucosal healing [185]. The gene discussed is RAC1; the disease is inflammatory bowel disease.